| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |